PLD
56
-4
CME
55
2
EMC
89
4
VNO
47
5
KMI
65
4
CMS
62
-5
PFE
38
-2
DVA
75
2
DHR
56
5
M
53
3
MS
76
2
WAT
64
3
EW
50
8
ILMN
30
5
SYY
56
2
PYPL
33
2
DG
30
2
HAL
46
2
CNX
67
6
FTI
89
3
PLD
56
-4
CME
55
2
EMC
89
4
VNO
47
5
KMI
65
4
CMS
62
-5
PFE
38
-2
DVA
75
2
DHR
56
5
M
53
3
MS
76
2
WAT
64
3
EW
50
8
ILMN
30
5
SYY
56
2
PYPL
33
2
DG
30
2
HAL
46
2
CNX
67
6
FTI
89
3
Financhill
Back

Par Pacific Holdings Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
25

PARR
Par Pacific Holdings

Last Price:
27.97
Seasonality Move:
4.24%
Sell
40

ITCI
Intra-Cellular Therapies

Last Price:
66.97
Seasonality Move:
-0.94%
Sell
25
Par Pacific Holdings (PARR) is a Sell

Is Par Pacific Holdings a Buy, Sell or Hold?

  • The current Par Pacific Holdings [PARR] share price is $28.36. The Score for PARR is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • PARR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $65.71. The Score for ITCI is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PARR Stock Price Chart

What is Par Pacific Holdings's stock price today?

  • The Par Pacific Holdings share price today is $28.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PARR is experiencing slight selling pressure.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $65.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing slight selling pressure.

PARR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.68 Sell
Relative Strength Index (14 RSI): 26.3 Sell
Chaikin Money Flow: -78876 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.72 - 33.38) Sell
Bollinger Bands (100): (32.53 - 38.41) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.03 Sell
Relative Strength Index (14 RSI): 41.38 Sell
Chaikin Money Flow: -338480 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.61 - 74.31) Sell
Bollinger Bands (100): (66.12 - 72.26) Sell

PARR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.49 Sell
20-day SMA: 30.91 Sell
50-day SMA: 34.45 Sell
200-day SMA: 34.75 Sell
8-day EMA: 29.45 Sell
20-day EMA: 31.01 Sell
50-day EMA: 33.33 Sell
200-day EMA: 33.28 Sell

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 67.56 Sell
20-day SMA: 70.79 Sell
50-day SMA: 68.73 Sell
200-day SMA: 62.69 Buy
8-day EMA: 67.37 Sell
20-day EMA: 69.06 Sell
50-day EMA: 69.19 Sell
200-day EMA: 64.61 Buy

Par Pacific Holdings Earnings Growth & PARR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.72 per share, a decrease next quarter of $0.16 per share, a decrease this year of $3.96 per share, and a decrease next year of $0.87 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.08 per share, and an increase next year of $1.44 per share.

Par Pacific Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):